Table 5.
Sites | Topography (ICD−10) | Total Number of Cancer Cases | Estimation of SI-EDI-I Coefficient 1 | 95% CI 3 | Estimation of SI-EDI-A 2 | 95% CI 3 |
---|---|---|---|---|---|---|
Head and neck | C00–C14, C30–C32 | 1278 | 0.071 | 0.060 to 0.082 | 0.021 | 0.001 to 0.021 |
Oesophagus | C15 | 241 | 0.056 | 0.031 to 0.082 | 0.061 | 0.022 to 0.096 |
Stomach | C16 | 1396 | 0.033 | 0.022 to 0.044 | 0.009 | −0.011 to 0.027 |
Colon and rectum | C18–C20 | 4398 | 0.028 | 0.021 to 0.034 | −0.004 | −0.015 to 0.006 |
Pancreas | C25 | 1030 | 0.038 | 0.026 to 0.051 | −0.002 | −0.025 to 0.021 |
Lung and trachea | C33–C34 | 3647 | 0.038 | 0.031 to 0.045 | 0.019 | 0.007 to 0.031 |
Skin, melanoma | C43 | 1471 | −0.054 | −0.076 to −0.032 | −0.021 | −0.042 to −0.800 |
Breast | C50 | 3692 | −0.003 | −0.012 to 0.007 | −0.018 | −0.031 to −0.005 |
Cervix | C53 | 377 | 0.022 | −0.005 to 0.049 | −0.001 | −0.036 to 0.033 |
Uterus | C54 | 928 | 0.033 | 0.019 to 0.046 | −0.020 | −0.045 to 0.003 |
Prostate | C61 | 4418 | −0.014 | −0.022 to −0.006 | −0.017 | −0.029 to −0.004 |
Testis | C62 | 302 | −0.050 | −0.105 to 0.004 | 0.003 | −0.035 to 0.041 |
Kidney | C64–C65 | 1057 | 0.006 | −0.010 to 0.023 | −0.011 | −0.034 to 0.011 |
Bladder | C67 | 926 | 0.022 | 0.008 to 0.036 | 0.002 | −0.023 to 0.026 |
Thyroid | C73 | 431 | −0.075 | −0.112 to −0.038 | −0.016 | −0.052 to 0.018 |
Non−Hodgkin’s lymphomas | C82−C85 | 1035 | 0.012 | −0.002 to 0.027 | −0.015 | −0.038 to 0.007 |
Leukaemias | C91−C95 | 704 | 0.013 | −0.004 to 0.031 | −0.012 | −0.040 to 0.015 |
1 Estimation of the coefficient related to SI-EDI-I. Positive for over-incidence in deprived individuals, negative otherwise. 2 Estimation of the coefficient related to SI-EDI-A for polling stations. Positive for over-incidence in deprived areas, negative otherwise. 3 95% confidence interval (CI), significant results are in bold type.